Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study

This publication has 9 references indexed in Scilit:

• HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
  Circulation, 1998
• The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome
  Rheumatology, 1997
• Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
  Annals of the Rheumatic Diseases, 1996
• ELEVATED von WILLEBRAND FACTOR ANTIGEN IN SYSTEMIC SCLEROSIS: RELATIONSHIP TO VISCERAL DISEASE
  Rheumatology, 1988
• Increased Factor VIII/von Willebrand Factor Antigen and von Willebrand Factor Activity in Scleroderma and in Raynaud's Phenomenon
  Annals of Internal Medicine, 1981
• Preliminary criteria for the classification of systemic sclerosis (scleroderma)
  Arthritis & Rheumatism, 1980
• Endothelial injury in scleroderma.
  The Journal of Experimental Medicine, 1979